Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer

Croatian Medical Journal

Volumn 46, Issue 3, 2005, Pages 389-396

  Bobinac, Dragica ^a   Marić, Ivana ^a   Zoričić, Sanja ^a   Španjol, Josip ^b   Dordević, Gordana ^a   Mustać, Elvira ^a   Fučkar, Željko ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; OSTEOGENIC PROTEIN 1; OSTEOGENIN;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METASTASIS POTENTIAL; OSTEOBLAST; OSTEOLYSIS; PROSTATE CANCER; PROTEIN EXPRESSION; REFERENCE VALUE; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEINS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 18844444202     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Orr FW, Sanchez-Sweatman OH, Kostenuik P, Singh G. Tumor-bone interactions in skeletal metastasis. Clin Orthop Relat Res. 1995;(312):19-33.
2. Mundy GR. Mechanisms of bone metastasis. Cancer. 1997;80(8 Suppl):1546-56.
3. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, et al. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer. 1998;78: 1219-23.
4. Rosai J. Bone and joints. In: Rosai J, editor. Rosai and Ackerman's surgcical pathology. Edinburgh (UK): Mosby; 2004. p. 2137-208.
5. Brandes D. Biologic characteristic of prostate carcinoma. In: Hill GS, editor. Uropathology. New York: Churchill Livingstone; 1989. p. 1259-64.
6. Paget S. The distibution of secondary growths in cancer of the breast. Lancet. 1889;1:571-3.
7. Jacob K, Webber M, Benayahu D, Kleinman HK. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res. 1999;59:4453-7.
8. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res. 1993;8 Suppl 2:S565-72.
9. Dickson RB, Lippman ME. Growth factors in breast cancer. Endocr Rev. 1995;16:559-89.
10. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
11. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A. 1981;78:7599-603.
12. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992;32:160-7.
13. Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am. 2001;83A (Pt 1-Suppl 1):S1-6.
14. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6:432-8.
15. Martinovic S, Borovecki F, Sampath KT, Vukicevic S. Biology of bone morphogenetic proteins. In: Vukicevic S, Sampath KT, editors. Bone morphogenetic proteins. From laboratory to clinical practice. Basel (Switzerland): Birkhauser Verlag; 2002. p. 121-44.
16. Shepherd TG, Nachtigal MW. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology. 2003;144:3306-14.
17. Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, et al. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res. 2004;64:7355-60.
18. Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol. 2004;20:695-723.
19. Asano N, Yamakazi T, Seto M, Matsumine A, Yoshikawa H, Uchida A. The expression and prognostic significance of bone morphogenetic protein-2 in patients with malignant fibrous histiocytoma. J Bone Joint Surg Br. 2004;86:607-12.
20. Yoshikawa H, Nakase T, Myoui A, Ueda T. Bone morphogenetic proteins in bone tumors. J Orthop Sci. 2004;9:334-40.
21. Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, et al. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer. 1992;66: 1159-63,
22. Hamdy FC, Autzen P, Robinson MC, Home CH, Neal DE, Robson CN. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res. 1997;57:4427-31.
23. Masuda H, Fukabori Y, Nakano K, Takezawa Y, Suzuki T, Yamanaka H. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate. 2003;54:268-74.
24. Thomas BG, Hamdy FC. Bone morphogenetic protein-6: potential mediator of osteoblastic metastases in prostate cancer. Prostate Cancer Prostatic Dis. 2000;3: 283-285.
25. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate. 1994;24:204-11.
26. Barnes J, Anthony CT, Wall N, Steiner MS. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol. 1995;13:337-43.
27. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, et al. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development. 1996;122: 2729-37.
28. Clement JH, Sanger J, Hoffken K. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int J Cancer. 1999;80:250-6.
29. Arnold SF, Tims E, Mcgrath BE. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine. 1999;11:1031-7.
30. Schwalbe M, Sanger J, Eggers R, Naumann A, Schmidt A, Hoffken K, et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol. 2003;23:89-95.
31. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization classification of tumors. Tumors of the urinary system and male genital organs. Lyon (France): IARC Press; 2004.
32. Tavassoli FA, Devilee P, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Lyon (France): IARC Press; 2003.
33. Robbins P, Finder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol. 1995;26:873-9.
34. Tietz NW, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase. J Clin Chem Clin Biochem. 1983;21:731-48.
35. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-10.
36. Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate. 1999; 39:246-61.
37. Partin AW, Coffey DS. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicle. In: Campbell MF, Retik AB, Vaughn ED, Walsh PC, editors. Campbell's urology. 7th edition. Philadelphia: Saunders; 1998. p. 1381-428.
38. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, et al. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res. 1997;57:5022-7.
39. Masuda H, Fukabori Y, Nakano K, Shimizu N, Yamanaka H. Expression of bone morphogenetic protein-7 (BMP-7) in human prostate. Prostate. 2004;59:101-6.
40. Weber KL, Bolander ME, Rock MG, Pritchard D, Sarkar G. Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms. J Orthop Res. 1998;16:8-14.
41. Noguchi M, Yahara J, Noda S. Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer. Urology. 2003;61:993-8.
42. Ware JL. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 1993;12:287-301.